Overview
The overall objective is to test the hypothesis that annual immunochemical faecal occult blood testing (iFOBT or FIT) is a feasible, safe, acceptable and cost-saving alternative to colonoscopy surveillance for the diagnosis of advanced adenomas (AA) and early stage colorectal cancer (CRC) in patients with intermediate risk colorectal adenomas as defined by national guidelines.
Further details
The study is led by Prof Wendy Atkin at Imperial College, London. Professor Stephen Duffy is the study statistician.
Contact
Professor Stephen Duffy
Email: s.w.dufy@qmul.ac.uk
Phone: +44 (0) 20 7882 3535